M Leal

752 total citations
23 papers, 371 citations indexed

About

M Leal is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, M Leal has authored 23 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 8 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in M Leal's work include Mosquito-borne diseases and control (10 papers), HIV Research and Treatment (5 papers) and Malaria Research and Control (5 papers). M Leal is often cited by papers focused on Mosquito-borne diseases and control (10 papers), HIV Research and Treatment (5 papers) and Malaria Research and Control (5 papers). M Leal collaborates with scholars based in Brazil, Spain and Switzerland. M Leal's co-authors include Akira Homma, Reinaldo de Menezes Martins, Marcos da Silva Freire, Luiz Antônio Bastos Camacho, Roberto Farias, Jussara Pereira do Nascimento, Maria de Lourdes S. Maia, Marcos S. Freire, Ricardo Galler and Anna M. Y. Yamamura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Vaccine and European Journal of Clinical Investigation.

In The Last Decade

M Leal

22 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Leal Brazil 10 258 213 101 49 45 23 371
Ricardo de Souza Carvalho Brazil 9 267 1.0× 200 0.9× 72 0.7× 11 0.2× 46 1.0× 26 327
Daniel Ewing United States 9 271 1.1× 284 1.3× 60 0.6× 18 0.4× 15 0.3× 13 389
Poh‐Lian Lim Singapore 8 421 1.6× 272 1.3× 62 0.6× 25 0.5× 11 0.2× 9 510
Maria dos Remédios Freitas Carvalho Branco Brazil 12 319 1.2× 184 0.9× 122 1.2× 38 0.8× 7 0.2× 40 518
Jayantha Liyanage United States 8 173 0.7× 177 0.8× 116 1.1× 42 0.9× 6 0.1× 9 316
Laurence Cibrelus Switzerland 10 304 1.2× 245 1.2× 63 0.6× 15 0.3× 12 0.3× 16 422
Wei Yee Leong Singapore 11 290 1.1× 234 1.1× 76 0.8× 41 0.8× 10 0.2× 15 404
Alena Khromava United States 6 121 0.5× 103 0.5× 70 0.7× 66 1.3× 17 0.4× 10 207
Jason Martin United States 11 89 0.3× 217 1.0× 178 1.8× 21 0.4× 6 0.1× 20 348
Esther M. Ellis United States 14 421 1.6× 323 1.5× 72 0.7× 7 0.1× 10 0.2× 31 568

Countries citing papers authored by M Leal

Since Specialization
Citations

This map shows the geographic impact of M Leal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Leal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Leal more than expected).

Fields of papers citing papers by M Leal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Leal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Leal. The network helps show where M Leal may publish in the future.

Co-authorship network of co-authors of M Leal

This figure shows the co-authorship network connecting the top 25 collaborators of M Leal. A scholar is included among the top collaborators of M Leal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Leal. M Leal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leal, M, et al.. (2020). A evolução regulatória e os desafios na perspectiva dos laboratórios públicos produtores de vacinas no Brasil. Cadernos de Saúde Pública. 36(suppl 2). e00202219–e00202219. 2 indexed citations
2.
Leal, M, et al.. (2018). Sanger-based sequencing technology for yellow fever vaccine genetic quality control. Journal of Virological Methods. 260. 82–87. 4 indexed citations
3.
Martins, Reinaldo de Menezes, M Leal, & Akira Homma. (2015). Serious adverse events associated with yellow fever vaccine. Human Vaccines & Immunotherapeutics. 11(9). 2183–2187. 45 indexed citations
4.
Martins, Reinaldo de Menezes, Ana Luiza Braz Pavão, Patrícia Mouta Nunes de Oliveira, et al.. (2014). Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil. Vaccine. 32(49). 6676–6682. 31 indexed citations
5.
Martins, Reinaldo de Menezes, Maria de Lourdes S. Maia, Roberto Farias, et al.. (2013). 17DD yellow fever vaccine. Human Vaccines & Immunotherapeutics. 9(4). 879–888. 74 indexed citations
6.
Martins, Reinaldo de Menezes, et al.. (2010). Yellow Fever Vaccine Post-marketing Surveillance in Brazil. 2(2). 178–183. 29 indexed citations
8.
Camacho, Luiz Antônio Bastos, et al.. (2005). Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial. Revista de Saúde Pública. 39(3). 413–420. 35 indexed citations
9.
Camacho, Luiz Antônio Bastos, et al.. (2004). Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial. Revista de Saúde Pública. 38(5). 671–678. 59 indexed citations
10.
Rabello, Ana, et al.. (2002). Low frequency of side effects following an incidental 25 times concentrated dose of yellow fever vaccine. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Rabello, Ana, et al.. (2002). Low frequency of side effects following an incidental 25 times concentrated dose of yellow fever vaccine. Revista da Sociedade Brasileira de Medicina Tropical. 35(2). 177–180. 9 indexed citations
12.
Rosa, Rafael de la, M Leal, Juan A. Pineda, et al.. (2001). Low Levels of HIV-1 Plasma Viral Load in Patients Infected with HIV-1 Subtype B and Advanced Immunosuppression. Journal of Infection. 42(1). 4–7. 2 indexed citations
13.
Camacho, Luiz Antônio Bastos, et al.. (2000). Estudo de soroconversão com formulações da vacina Biken CAM-70 contra sarampo. Revista de Saúde Pública. 34(4). 358–366. 3 indexed citations
14.
Macı́as, Juan, Juan A. Pineda, Juan Delgado, et al.. (1997). Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.. PubMed. 11(2). 253–4. 8 indexed citations
15.
Leal, M, Yolanda Torres, F. Relimpio, et al.. (1996). Rate of development of mutation at codon 215 of HIV‐1 reverse transcriptase and its predictive factors at the time of initiation of zidovudine therapy. European Journal of Clinical Investigation. 26(6). 476–480. 8 indexed citations
16.
Soriano, Vincent, Raúl Ortíz de Lejarazu, Antonio Aguilera, et al.. (1993). [A multicenter study of infection with human immunodeficiency virus type-2 (HIV-2) in Spain (1991). The Spanish Group for the Study of HIV-2].. PubMed. 100(14). 531–5. 1 indexed citations
17.
Leal, M, Michael Hayes, & Mark L. Powell. (1992). The metabolism of CGS—15873 in man using stable isotope pattern recognition techniques. Biopharmaceutics & Drug Disposition. 13(8). 617–628. 3 indexed citations
18.
Pineda, Juan A., et al.. (1986). [Prevalence of anti-LAV/HTLV-III in prostitutes in Seville].. PubMed. 86(12). 498–500. 2 indexed citations
19.
Velardo, A, et al.. (1986). [Absence of antibodies against the acquired immune deficiency syndrome virus in hospital personnel in contact with risk groups].. PubMed. 86(3). 132–132. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026